-
Is assisted reproduction included in health insurance?
Time of Update: 2022-04-30
Significance of assisted reproduction included in medical insuranceSignificance of assisted reproduction included in medical insuranceThe inclusion of assisted reproduction in medical insurance has three important significances:(1) Reduce the burden of infertile couples and increase the penetration rate of assisted reproductionAfter the implementation of Beijing's medical insurance adjustment policy, IVF technology can cover laboratory technologies ranging from 8,000 yuan to 11,000 yuan .
-
Could Alzheimer's disease be detected 15 years earlier?
Time of Update: 2022-04-30
▲In the AD cohort, the incidence of health problems significantly related to AD, the trend over time (Image source: Reference [1])The paper concludes that these results provide new evidence of underlying risk factors and early signs associated with Alzheimer's disease, which can be observed in primary care settings, and can be used for primary prevention and treatment of Alzheimer's disease.
-
The "lost" "life" of the vaginal flora changes the outcome of pregnancy
Time of Update: 2022-04-30
Therefore, regulating and improving the vaginal microecology of pregnant women is a feasible method to prevent vaginal diseases during pregnancy, and lactic acid bacteria preparations are widely used in the treatment of female lower genital tract diseases (Table 1) .
-
Shanghai Anhan Digestive Tract Vibrating Capsule System was approved by the State Food and Drug Administration
Time of Update: 2022-04-30
It is understood that the product stimulates the colon wall through vibration, promotes colonic peristalsis, and provides a new treatment method for functional chronic transit constipation in adults with poor drug treatment effect .
-
A new coronavirus-related detection kit from Kaipu Bio has obtained an invention patent
Time of Update: 2022-04-30
On February 22, Kaipu Bio announced that the company and its wholly-owned subsidiaries Kaipu Pharmaceutical, Kaipu Chemical, and its holding subsidiary Shanghai Kaipu Laboratory have recently received
-
New discovery!
Time of Update: 2022-04-30
Recently, researchers from Tianjin Medical University published a research article entitled "CBX2 and EZH2 cooperatively promote the growth and metastasis of lung adenocarcinoma" in the journal Molecular Therapy: Nucleic Acids, which revealed that chromatin box protein 2 (CBX2) and histone lysine N-methyltransferase (EZH2) in promoting lung adenocarcinoma (LUAD) progression, thus providing a potential target for the diagnosis and treatment of LUAD .
-
Takeda's Alofisel has a significant effect in the treatment of patients with Crohn's disease: the clinical remission rate is 65%!
Time of Update: 2022-04-30
Takeda today announced the results of the first 6-month interim analysis of the INSPIRE study of its allogeneic adipose-derived mesenchymal stem cell product, Alofisel (darvadstrocel), in the treatment of complex perianal fistulas (CPF) in patients with Crohn's disease (CD).
-
New progress in lipid nanoparticles technology for targeted delivery of mRNA into lung tissue
Time of Update: 2022-04-30
The experimental results show that this LNP can highly efficiently deliver Tsc2 mRNA into lung cells, restore Tsc2 function, and significantly reduce tumor burden in mice .
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.
PNAS, https://doi.
-
PADN-CFDA multi-center half-year follow-up data pre-announced positive clinical performance
Time of Update: 2022-04-30
When the effect of drug treatment reaches the "ceiling" and pulmonary artery pressure cannot be controlled, can interventional therapy improve the prognosis of patients?Professor Yang Zhenwen from the General Hospital of Tianjin Medical University shared his experience in the treatment of connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH).
-
Tiny tire particles inhibit biological growth in freshwater, coastal estuaries, study finds
Time of Update: 2022-04-30
Small particles from tires inhibit the growth of organisms found in freshwater and coastal estuarine ecosystems and lead to adverse behavioral changes, OSU scientists have found in two new research papers .
-
Targeting Immune Diseases and Cancer $84M to Help Develop SIRP-Targeted Therapies
Time of Update: 2022-04-30
▲ Pathological mechanism of sHLH (Image source: Electra official website)References:[1] Electra Therapeutics Announces $84 Million Series B Financing and Unveils Its Novel SIRP‑Targeted Therapies for Immunological Diseases and Cancer.
Retrieved February 16, 2022, from https:// Electra-Therapeutics-Announces-84-Million-Series-B-Financing-and-Unveils-Its-Novel-SIRP%E2%80%91Targeted-Therapies-for-Immunological-Diseases-and-Cancer(Original abridged)
-
Neuron 'repair agent' may be 'part-time' to treat infertility
Time of Update: 2022-04-30
Studies have shown that in two animal models of premature ovarian failure, treatment with new antibody drugs can effectively maintain and promote follicle development, restore hormone homeostasis, and inhibit ovarian cell apoptosis .
-
Antibiotics used on food crops affect bumblebee behavior, lab study finds
Time of Update: 2022-04-30
"No one has studied the potential effects of broadcast spraying of antibiotics on pollinators in agriculture, despite their widespread use," said Laura Avila, co-first author of the paper and a postdoctoral researcher in Emory's Department of Biology.
-
Aquatic animals + growing rice can increase yields, reduce chemical use
Time of Update: 2022-04-30
"One example includes farmers experimenting with growing aquatic animals in paddy fields," said lead author Liang Guo, a postdoctoral fellow at Zhejiang University's School of Life Sciences .
-
"Head" and other important matters, please pay attention!
Time of Update: 2022-04-30
At 48 weeks (third endpoint), the greatest increase in total hair count was found with oral 5 mg/d finasteride, which was significantly more effective than 2% minoxidil .
-
Opdivo+Yervoy is similar to Keytruda+Inlyta!
Time of Update: 2022-04-30
According to the results of a study presented recently at the 2022 American Society of Clinical Oncology Genitourinary Cancer Symposium (ASCO GU), the "dual immunization" regimen Opdivo (nivolumab, nivolumab) + Yervoy (ipilimumab, ipilimumab) Muma) and the "immune + targeting" regimen Keytruda (pembrolizumab, pembrolizumab) + Inlyta (axitinib, axitinib) first-line treatment of metastatic renal cell carcinoma with poor performance status (poor PS) (mRCC) patients, there were no significant differences in overall response rate (ORR), progression-free survival (PFS), and overall survival (OS) .
-
Can AIDS be cured?
Time of Update: 2022-04-30
Abstract: Bone marrow transplantation containing the CCR5 mutation gene may be suitable for the treatment of patients of different races and genders who suffer from AIDS and blood cancer at the same time .
-
The new "revolution" of cell therapy, a number of giant companies in NK therapy have joined forces
Time of Update: 2022-04-30
The therapy CYNK-001 is a cryopreserved allogeneic ready-to-use NK cell therapy, unmodified, containing CD56+/CD3-NK cells expanded from human placental CD34+ cells, intended to be developed for the treatment of the blood system Malignant tumors, solid tumors and infectious diseases .
-
14 products of Sino Bio have obtained medical device registration certificate
Time of Update: 2022-04-30
Insulin (INS) detection kit (chemiluminescence immunoassay) for the quantitative determination of the content of insulin (INS) in human serum or (and) plasma in vitro;12.
C-peptide (CP) detection kit (chemiluminescence immunoassay) for quantitative determination of the content of C-peptide (CP) in human serum or (and) plasma in vitro;14.
-
Treatment of Breast, Colon and Pancreatic Cancers Nature Study Finds Potential New Combination Therapy
Time of Update: 2022-04-30
The researchers systematically evaluated 2,025 two-drug combinations using 125 tumor cell lines, including breast, colorectal, and pancreatic cancer cell lines .
